TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05781776

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Otago exercises and core strengthening
Description: Otago exercise program consisted of strengthening and balance exercises. The strengthening exercises focus on major lower limb muscles. Progression of exercises was done by increasing the duration and then intensity.~Balance exercises involved knee bends, backward walking, walking, and turning around, sideways walking, tandem stance (heel to toe), tandem walk (heal to toe walk), one leg stand, heel walking, toe walk, heel to toe walking backward, sit to stand and stair walking. Balance exercises progressed with varying levels of support depending on their balance and confidence. The individuals repeated each exercise 10 times.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Gaze stability exercises and core strengthening
Description: The exercise protocol in Gaze Stability exercises included adaptation exercises and substitution exercises. In adaptation exercises, individuals performed rapid, active head rotations while watched a visual target with the target remaining stationary. Substitution exercises, individual performed eye-head movements between targets with the goal of seeing clearly during the task. That target moved in the opposite direction of head movement.~Adaptation exercises included: Horizontal and vertical (stationary target) viewing exercises done with a near target, sitting. Horizontal and vertical (stationary target) viewing exercises done with near and far targets (6-10 feet), sitting. Horizontal and vertical (stationary target) viewing exercises were done with near and far targets, standing.
Study: NCT02438319

Intervention type: OTHER
Intervention: manual planimetry
Description: Manually marking of the boundaries of the optic disc and it's excavation on color photographs of the optic disc.

Intervention type: OTHER
Intervention: automated planimetry
Description: Automatic detection of the boundaries of the optic disc and it's excavation on color photographs of the optic disc.
Study: NCT01080378

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Dietary and Exercise Intervention
Description: Participants will be enrolled into a 16 weeks weight loss programme that consists of (a) dietary interventions and (b) structured exercise sessions and (c) physical activity to achieve 7 - 10% decrease (more than 8 kg) in initial body weight in 16 weeks. They will be subjected to a caloric deficit of 40% of the subject's energy expenditure or 1000kcal, which ever it is higher. (allowance given for dietary control and physical activity).

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Dietary and Exercise Intervention
Description: Participants will be enrolled into a 16 weeks weight loss programme that consists of (a) dietary interventions and (b) structured exercise sessions and (c) physical activity to achieve 7 - 10% decrease (more than 8 kg) in initial body weight in 16 weeks. They will be subjected to a caloric deficit of 40% of the subject's energy expenditure or 1000kcal, which ever it is higher. (allowance given for dietary control and physical activity).

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Dietary and Exercise Intervention
Description: Participants will be enrolled into a 16 weeks weight loss programme that consists of (a) dietary interventions and (b) structured exercise sessions and (c) physical activity to achieve 7 - 10% decrease (more than 8 kg) in initial body weight in 16 weeks. They will be subjected to a caloric deficit of 40% of the subject's energy expenditure or 1000kcal, which ever it is higher. (allowance given for dietary control and physical activity).
Study: NCT02189356

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise programme
Description: The study was a prospective randomized trial with a control group (standard care group) and an intervention group, using a repeated measures design. Forty-eight pregnant participants with pregnancy-related LBPP were included in the control group and 48 pregnant participants with pregnancy-related LBPP were included in the intervention (exercise) group

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: standard care
Description: standard pregnancy follow up
Study: NCT01363167

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: 400 IU Cholecalciferol- Vitamin D Daily
Description: Infants who are defined as vitamin D deficient at birth will be randomized to receive either 400 IU vitamin D/day or placebo daily until term age is reached.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: 400 IU Cholecalciferol- Vitamin D Daily
Description: Infants who are defined as vitamin D deficient at birth will be randomized to receive either 400 IU vitamin D/day or placebo daily until term age is reached.
Study: NCT01376349

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prasterone
Description: Applied vaginally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prasterone
Description: Applied vaginally

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Applied vaginally
Study: NCT00162032

Intervention type: DRUG
Group type: OTHER
Intervention: Sestamibi
Description: Sestamibi

Intervention type: DRUG
Group type: OTHER
Intervention: Sestamibi
Description: Sestamibi
Study: NCT02442713

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fluvoxamine
Description: fluvoxamine: 50-300mg/day
Study: NCT00922103

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ileal Neo Rectal Anastomosis
Description: Comparison of the Ileal Neo Rectal Anastomosis to the Ileal Pouch Anal Anastomosis in patients treated for medical refractory Ulcerative Colitis

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ileal Pouch Anal Anastomosis
Description: Comparison of the Ileal Pouch Anal Anastomosis to the Ileal Neo Rectal Anastomosis in patients treated for medical refractory Ulcerative Colitis
Study: NCT04027231

Intervention type: OTHER
Intervention: analysis of the synovial fluid
Description: Electrochemical cell analysing the patients' synovial fluid whenever an invasive intervention is medically prescribed

Intervention type: OTHER
Intervention: analysis of the synovial fluid
Description: Electrochemical cell analysing the patients' synovial fluid whenever an invasive intervention is medically prescribed

Intervention type: OTHER
Intervention: analysis of the synovial fluid
Description: Electrochemical cell analysing the patients' synovial fluid whenever an invasive intervention is medically prescribed

Intervention type: OTHER
Intervention: analysis of the synovial fluid
Description: Electrochemical cell analysing the patients' synovial fluid whenever an invasive intervention is medically prescribed

Intervention type: OTHER
Intervention: analysis of the synovial fluid
Description: Electrochemical cell analysing the patients' synovial fluid whenever an invasive intervention is medically prescribed
Study: NCT00882453

Intervention type: DRUG
Intervention: Interferon beta-1b (Betaseron, BAY86-5046)
Description: Intravenous therapy according to product information
Study: NCT02701426

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: physical activity and nutritional counseling
Description: The program will last 12 weeks, and will include three workshops on diet of the pregnant and lactating women, and the young child. Physical activity sessions will be offered once a week.
Study: NCT03513874

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Patients will be subscribed with 850mg metformin orally twice daily. Insulin will be continued as routine therapy.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin
Description: Patients will continue insulin therapy following physicians' instructions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin
Description: Patients will continue insulin therapy following physicians' instructions.
Study: NCT03952806

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Verdiperstat
Description: 300mg 2 oral tablets, twice daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study: NCT02467218

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hyperbaric Oxygen Treatment
Description: Baseline and follow up fMRI and Oxygen treatment, 90 minutes, once daily, five times a week for 8 consecutive weeks in the hyperbaric chamber (40 treatments with 100% oxygen at 2.0 ATA)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hyperbaric Oxygen Treatment
Description: Baseline and follow up fMRI and Oxygen treatment, 90 minutes, once daily, five times a week for 8 consecutive weeks in the hyperbaric chamber (40 treatments with 100% oxygen at 2.0 ATA)
Study: NCT02557321

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PV-10
Description: PV-10 will be administered by intralesional injection every 3 weeks at Day 1 (Week 1), Week 4, Week 7, Week 10 and Week 13

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PV-10
Description: PV-10 will be administered by intralesional injection every 3 weeks at Day 1 (Week 1), Week 4, Week 7, Week 10 and Week 13

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab will be administered intravenously every 3 weeks starting at Day 1 (Week 1)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab will be administered intravenously every 3 weeks starting at Day 1 (Week 1)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: Pembrolizumab will be administered intravenously every 3 weeks starting at Day 1 (Week 1)
Study: NCT01742598

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Portico Transapical Aortic Valve System
Study: NCT02136420

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Promethazine
Description: Subject receives promethazine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Promethazine
Description: Subject receives promethazine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Promethazine
Description: Subject receives promethazine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Promethazine
Description: Subject receives promethazine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Promethazine
Description: Subject receives promethazine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Promethazine
Description: Subject receives promethazine

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hyper gravity training
Description: Subject receives hypergravity training before testing

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hyper gravity training
Description: Subject receives hypergravity training before testing

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hyper gravity training
Description: Subject receives hypergravity training before testing

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hyper gravity training
Description: Subject receives hypergravity training before testing

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: No hypergravity training
Description: Subjects do not receive normal Earth gravity

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No hypergravity training
Description: Subjects do not receive normal Earth gravity

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: No hypergravity training
Description: Subjects do not receive normal Earth gravity
Study: NCT00003469

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antineoplaston therapy (Atengenal + Astugenal)
Description: Children with a Rhabdoid tumor will receive Antineoplaston therapy (Atengenal + Astugenal).
Study: NCT01966016

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pacing
Description: In this study we intend to include patients that have indication to and are intended to undergo CRT implantation with an additional electrode on LV, that have inclusion criteria and have signed an informed consent.~In this study we will include 20 patients for each study arm (overall 100)- each patient will have both treatment configurations and these two will be compared

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pacing
Description: In this study we intend to include patients that have indication to and are intended to undergo CRT implantation with an additional electrode on LV, that have inclusion criteria and have signed an informed consent.~In this study we will include 20 patients for each study arm (overall 100)- each patient will have both treatment configurations and these two will be compared
Study: NCT02057185

Intervention type: BEHAVIORAL
Intervention: Study questionnaire
Description: Questionnaire based on work situation of enrolled patients.

Intervention type: BEHAVIORAL
Intervention: SF-36 Questionnaire
Description: Version 1.6
Study: NCT01065727

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mitoxantrone - immunomodulator
Description: mitoxantrone during 6 months and followed by immunomodulator during 2 years and half

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: natalizumab
Description: monthly natalizumab during 3 years
Study: NCT02379728

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PrenaBelt
Description: The PrenaBelt (PB) is a belt-like, positional therapy (PT) device designed for pregnant women. While the PB does not prevent the user from lying on her back during sleep, it is expected to significantly decrease the amount of time a user spends supine via the mechanism of PT. PT is a simple, non-invasive, inexpensive, long-established, safe, and effective intervention for preventing people with positional-dependent snoring or obstructive sleep apnea from sleeping on their back - a position that exacerbates their condition.~The PB is worn at the level of the waist or thorax. By design, the PB affects subtle pressure points on the user's back while supine, activating her body's natural mechanism to reposition itself to relieve discomfort, thereby reducing the amount of time spent supine.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PrenaBelt
Description: The PrenaBelt (PB) is a belt-like, positional therapy (PT) device designed for pregnant women. While the PB does not prevent the user from lying on her back during sleep, it is expected to significantly decrease the amount of time a user spends supine via the mechanism of PT. PT is a simple, non-invasive, inexpensive, long-established, safe, and effective intervention for preventing people with positional-dependent snoring or obstructive sleep apnea from sleeping on their back - a position that exacerbates their condition.~The PB is worn at the level of the waist or thorax. By design, the PB affects subtle pressure points on the user's back while supine, activating her body's natural mechanism to reposition itself to relieve discomfort, thereby reducing the amount of time spent supine.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Body Position Sensor
Description: The Body Position Sensor (BPS) is for research purposes only. The BPS can be securely integrated into a pocket on the PrenaBelt (PrenaBelt with BPS Arm) or sham-PrenaBelt (Control with BPS Arm). The BPS is a small, electronic data acquisition device. The BPS uses a three axes accelerometer to detect orientation of the PrenaBelt, and thus the user (right, left, prone, supine), in three-dimensional space. The accelerometer data is collected continually with time stamping and stored on the BPS hard drive and can be accessed via connecting it to a computer. The BPS is not expected to affect the body position of the user.
Study: NCT02136420

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No hypergravity training
Description: Subjects do not receive normal Earth gravity
Study: NCT04835701

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music
Description: Music may be played through a portable speaker in close proximity to the patient or through the patient's own headphones, if preferred. Music will be played at a low enough volume for subjects to hear standard anticipatory guidance during the procedure.
Study: NCT03963687

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Nursing Education Intervention
Description: Genetics Education Program for Nurses (GEPN) which is available free online for more than 20 years

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: New Nursing Education Intervention
Description: Web-based Genomics/ Genetics Nursing Education is a free online course that will be designed by the research team.
Study: NCT02569957

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topotecan Hydrochloride
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topotecan Hydrochloride
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetylcysteine
Description: Given IV and PO
Study: NCT04376853

Intervention type: DEVICE
Intervention: Apple Watch Series 5
Description: Digital monitoring via Apple Watch
Study: NCT01917019

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matching placebo tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB041 (fampridine)
Description: fampridine prolonged-release tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB041 (fampridine)
Description: fampridine prolonged-release tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB041 (fampridine)
Description: fampridine prolonged-release tablets
Study: NCT04395430

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Participants will receive standard care which consist of the following:~* a lifestyle counseling visit~* educational materials~* goal-setting by a healthcare professional, and~* information about general weight management resources.~* weighing scale and measuring tape with instructions to use~* fitness tracker

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Usual Care
Description: Participants will receive standard care which consist of the following:~* a lifestyle counseling visit~* educational materials~* goal-setting by a healthcare professional, and~* information about general weight management resources.~* weighing scale and measuring tape with instructions to use~* fitness tracker

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: online KKH Sports Singapore Program with Usual Care
Description: Participants will receive standard care and basic sports equipment and cooking materials for the online programme.~The online programme will be available up to 4 days per week (Weekdays evenings and Weekends mornings or early afternoons) and all household family members are invited to participate. The majority of the programming will be run by trained research coordinator and volunteers from KKH and Sports Singapore coaches. A regular rotation of comprehensive programming is provided, which includes online fitness, cooking, nutrition, and peer support classes. Every session includes up to 60 minutes of exercise and/or active play, and each session has an additional special 'theme.' For example, one to two sessions per week includes nutrition related programming (e.g., cooking classes), parent specific activities (e.g., a yoga class), peer support sessions (e.g., small group discussions around issues such as weight stigmatization), and fitness classes (e.g., soccer classes).
Study: NCT03401541

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcifediol
Description: One capsule of 900 micrograms of 25(OH)D

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcifediol
Description: One capsule of 900 micrograms of 25(OH)D

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcifediol
Description: One capsule of 900 micrograms of 25(OH)D

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcifediol
Description: One capsule of 900 micrograms of 25(OH)D

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calciferol
Description: One capsule of 900 micrograms of Vitamin D

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calciferol
Description: One capsule of 900 micrograms of Vitamin D

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calciferol
Description: One capsule of 900 micrograms of Vitamin D

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calciferol
Description: One capsule of 900 micrograms of Vitamin D
Study: NCT01847118

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevacizumab
Study: NCT03595605

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ambulation
Description: This group will be encouraged twice daily to ambulate

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Care as usual at inpatient NYU Langone
Study: NCT04175002

Intervention type: DRUG
Intervention: utrogestan
Description: oral uterogeston 200mg daily to achieve window of implantation from previous study

Intervention type: DRUG
Intervention: utrogestan
Description: oral uterogeston 200mg daily to achieve window of implantation from previous study
Study: NCT03840226

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Placebo tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Magnesium Oxide
Description: Magnesium tablets
Study: NCT01708213

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aline HA
Description: Implantable dermal filler